PO-0768: Localization methodology for water-equivalent plastic scintillation detectors using surrogate fiducials in CT  by Kudchadker, R.J. et al.
2nd ESTRO Forum 2013   S289 
Materials and Methods: The heterogeneous phantom was developed 
in the frame of IAEA Coordinated Research Project. The phantom 
consists of frame made with polystyrene and bone or lung equivalent 
inhomogeneity slabs. Special inserts allow to position TLD capsules 
within the polystyrene below the bone or lung material and also 
within the lung equivalent material. Additionally, there are inserts 
that allow for positioning the ionization chamber and films in the 
phantom. This enables comparisons of the doses calculated by TPSs 
for specific treatment fields in specified points with the 
measurements performed with various detectors. The comparisons 
were performed for a number of TPS (Eclipse from Varian, XiO, from 
CMS, Oncentra MasterPlan from Nucletron, Panther from Prowess, 
PrecisePlan fromElecta, Pinacle from Philips) and for a number of 
linear accelerators (Varian, Siemens, Elekta) in several radiotherapy 
departments in Poland in the framework of the Quality Assurance 
Audit programme in Poland. 
Results: Seven Polish radiotherapy centers (of 28 in total) were 
audited. Six different TPSs and eleven calculation algorithms were 
examined. Generally, most of the results obtained with TLD and 
ionizing chamber were within 5% tolerance. Differences between 
doses calculated by TPSs and measured with TLD did not exceed 4% 
for bone equivalent and polystyrene materials. Under the lung 
equivalent material, on the beam axis the differences were lower 
than 5% whereas inside the lung material, off the beam axis – in some 
cases were about 7%.  
Differences of doses measured with ionizing chamber under 
polystyrene and bone or lung equivalent materials were lower than 
5%, whereas inside the lung material the difference was 5,2%. 
Conclusions: The comparison of results for calculations and the 
measurements allow for the detection of limitations of TPS calculation 
algorithms. The audits performed with the use of heterogeneous 
phantom seem to be an effective tool for detecting the errors in basic 
data configuration and the TPS performance at the audited 
radiotherapy departments.  
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Purpose/Objective: Recent developments of new therapy techniques 
using small beams, such as stereotactic radiotherapy, require new 
detectors to precisely determine the delivered dose. The dosimeter 
has to be as close as possible to tissue equivalence and exhibit a small 
detection volume compared to the size of the irradiation field, 
because of the lack of lateral electronic equilibrium. Characteristics 
of single crystal diamond (tissue equivalent material Z=6, high 
density) make it an ideal candidate to fulfill most of the small beam 
dosimetry requirements. 
Materials and Methods: We developed single crystal diamond 
dosimeters (SCDDo) with a small detection volume (<0.4 mm3). The 
Monte-Carlo code PENELOPE (parallelized version) was used to 
optimize the encapsulating material and electrodes of our diamond 
detectors, in order to obtain a tissue equivalent detector. Response 
time, stability and repeatability of the detector were tested under 
Co60 source irradiation. SCDDo dose profile, depth dose and output 
factor measurements, were performed for small beams using two 
stereotactic systems: Varian Clinac 2100 C linear accelerator with 
micro MLC m3 and a Novalis TX linear accelerator. These 
measurements were compared to different detectors, both active and 
passive: diode, micro-LiF (TLD), EBT2 radiochromic film, PinPoint 
ionization chamber. 
Results: SCDDo presents an excellent spatial resolution for dose 
profile measurements, due its small detection volume. OFs obtained 
with SCDDo are very satisfactory from 0.6 x 0.6 cm2 to 10 x 10 cm2 
field sizes, compared to PinPoint ionization chamber which 
underestimates OF values in small beam. 
Conclusions: SCDDo respects the small beam dosimetry requirements 
(tissue-equivalence, small detection volume). The absorbed dose 
measurements obtained with this device are very satisfying compared 
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Purpose/Objective: Radiochromic dosimeters are promising within 
radiotherapy due to the ability to measure dose distributions in 3D 
with high resolution. However, the response to irradiation is low 
compared to clinical relevant dose levels. Improvements of the dose 
response may be found through knowledge of the chemical structure 
of the dosimeter. In this study we therefore examined the nanoscale 
structures in a radiochromic dosimeter that was based on a leuco 
malachite green dye and the surfactant sodium dodecylsulfate (SDS) 
suspended in a gelatin matrix.  
Materials and Methods: The original dosimeter formulation 
investigated consisted of 6 % (w/w) gelatin that formed the volume of 
the 3D dosimeter, 50 mM sodium dodecyl sulfate (SDS) was added as 
surfactant, 5 mM trichloroacetic acid as initiator, 0.37 mM leuco 
malachite green (LMG) as active component and 80 mM 
trichloromethane was added to dissolve the LMG. Small-angle x-ray 
scattering was then used to investigate the structures of a range of 
compositions of the dosimeter by omitting different components of 
the dosimeter formulation. 
Results: When omitting gelatin ellipsoidal micelles of SDS were 
formed with a core radius near 15 Å and shell thickness near 7 Å 
(figure 1).Gelatin significantly changed the micelles to a cylindrical 
shape with around three times lower core radius and four times larger 
shell thickness, which indicates that the gelatin is present in the shell 
and the outer part of the core. 
  
Conclusions: It was possible to measure the individual dosimeter 
components effect on the chemical structures of the dosimeter. Using 
knowledge of the chemical structure, it might be possible to construct 
an improved dosimeter with a clinical relevant dose response by 
modifying the chemical composition and thereby the micelle 
structures.  
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Purpose/Objective: To quantify the accuracy of a method to localize 
the sensitive volume of water equivalent in-vivo plastic scintillation 
detectors (PSDs) on Computerized Tomography (CT) images. PSDs 
when inserted in patients cannot be directly visualized on CT images 
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due to their water equivalency (i.e. they cannot be differentiated 
from tissue), but accurate localization is necessary for comparison of 
measured dose to dose calculated on CT images. 
Materials and Methods: We constructed two mock PSDs with CT-radio-
opaque metal wire used in place of scintillating fibers. Each mock 
detector was constructed to the specifications of in-vivo PSDs being 
used at our institution and consisted of a 7 mm graphite spacer, 2 mm 
of radio-opaque wire coupled to a clear plastic optical fiber contained 
in black polyethylene jacketing. 2 mm spherical ceramic fiducials 
were attached at the end of the detector and to either side of the 
detector 1 cm distal to the wire as surrogates for calculating the 
location of the ‘sensitive volume’. The detectors were attached to an 
endorectal balloon which was subsequently inserted into an 
anthropomorphic prostate phantom and inflated. A CT scan (2.5 mm 
slice thickness, the same used when imaging in-vivo detectors in 
patients) of the phantom was then acquired, and the resulting images 
imported into the Pinnacle treatment planning system. A script then 
determined the location of the active volume by calculating a line 
between the center of the proximal fiducial and a point halfway 
between the two distal fiducials (i.e. the center of the optical fiber) 
and contouring 1 mm diameter circles around the line on slices 
containing the portion of the line between 8 mm and 10 mm. The 
locations of the resulting contours were compared to the location of 
the metal wire. This process was repeated ten times – removing and 
deflating the balloon, detaching the detectors, and then re-setting up 
the experiment completely each time. 
Results: The average deviation in the axial plane between the center 
of the contours and the center of the metal wire was 0.1 mm in the 
anterior direction (Figure 1). The root-mean-square deviation was 0.4 
mm. All contours were within 0.8 mm of the actual location. 13 out of 
20 measurements were localized to the correct axial slice, and the 
other 7 were one slice off. Axial discrepancies were considered more 
important than SI discrepancies because the dose gradient of patient 
treatment plans lies primarily along the AP direction. The direction 
and magnitude of the deviation from actual location for all 20 
measurements are shown in Figure 1. 
 
  
Conclusions: The methodology for contouring the sensitive volume of 
a scintillation detector was found to consistently produce contours in 
good agreement with the position of the detector’s sensitive volume. 
This method can be used to effectively localize the actual PSDs within 
an accuracy of less than 0.8 mm.  
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Purpose/Objective: Medical linear accelerators (linacs) capable of 
delivering flattening filter free (FFF) beams present a promising 
option for radiotherapy clinics due to potentially reduced treatment 
times and lower doses out of field. However, successful treatment 
outcome depends on the accuracy of the commissioning data loaded 
into treatment planning systems - especially for treatments involving 
small or composite fields. A comparison of beam data between 
dosimetry methods is therefore required to assess the uncertainties on 
dose estimates. Differences in response of different dosimetry 
methods, primarily due to energy dependence, have been discussed in 
the literature for conventional flattened (FF) beams. However, it is 
not obvious that the same differences apply in FFF beams. To assess 
this, we present measurements of central dosimetric parameters, 
obtained using three different dosimetry methods in FFF beams. 
Materials and Methods: Measurements were performed in water for a 
Varian TrueBeam not yet commissioned for FFF beams. The 
measurements concerned i) output factors, ii) TPR20:10 ratios, and iii) 
dose per pulse. Output factors and TPR20:10 measurements were 
acquired for 6 MV and 10 MV beams operated in FFF mode, using i) a 
fibre-coupled organic scintillator, ii) a PTW 60003 diamond detector 
and iii) an IBA CC13 ionization chamber. To accurately determine the 
increase in instantaneous dose rate when removing the flattening 
filter, the dose per pulse was measured using the fibre-coupled 
organic scintillator for FFF as well as FF beams. 
Results: The table shows measured output factors (mean ± 1 SD) 
obtained at 90 cm source to surface distance and 10 cm depth. 
Differences between detectors were significant for large fields, 
amounting to 3.2 % at the largest. Conversely, differences of up to 2.8 
% between the scintillator and diamond were seen for small fields. 
Measurements of TPR20:10 ratios were more consistent, agreeing to 
within 0.8 % for the three dosimetry methods. The measured dose per 
pulse was 2.7 times higher for 6 MV FFF than for 6 MV FF, and 4.6 
times higher for 10 MV FFF than for 10 MV FF, comparing well with 
literature values of FFF beam output (Int J Radiat Oncol Biol Phys 80, 
1228-1237, 2011). 
Conclusions: The presented measurements show that detector-
inherent differences in output factor measurements are also 
encountered in FFF beams. The over-response of diamonds has been 
discussed in the literature for FF beams (Phys Med Biol 57, 4461-4476, 
2012); similarly, differences between ionization chambers and 
scintillators have been reported for 6 MV large fields (Med Phys 38, 
2140-2150, 2011). We conclude that these findings also apply in FFF 
beams. However, the needed correction factors for ionization 
chambers and diamonds are larger for FFF beams due to the higher 
dose per pulse. To further assess dosimetric uncertainties, a logical 
next step would be to compare beam data for linacs situated at 
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Purpose/Objective: EBT2 and EBT3 radiochromic films are 
characterized by a high spatial resolution that can’t be matched by 
two-dimensional ion chamber or diode arrays. Thanks to this property 
they seem to be ideal dosimeters for the verification of TomoTherapy 
stereotactic body radiation therapy (SBRT) plans. Their response is 
degraded by two different sources: acquisition process related 
distortion; inherent dose sensitivity variations. Moreover this non-
uniformities convolve with the regular dose fluctuation pattern 
inherent to helical dose delivery. In this study a protocol that allows 
to reduce the spatial non-uniformity to a clinically acceptable level 
was investigated. 
Materials and Methods: Dose sensitivity variations was quantified for 
different film batches by delivering a uniform dose distribution with a 
standard linear accelerator. The frequency range that characterized 
noise bands was identified with a band-pass filter. 10 TomoTherapy 
SBRT plans were delivered on EBT2-3 films. Films were digitized with 
an Epson scanner and the resulting images were converted in net 
